These Drugs Could Save the U.S. Billions of Dollars. Would You Take Them?
They used to be considered unlikely challengers to brand-name biologic drugs. Now some estimate (PDF) that they could save the U.S. health-care system tens of billions of dollars by 2024—once they win regulators' approval.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.